throbber
ROITT’S .
`
`ESSENTIAL
`
`IMMUNOLOGY
`
`Ivan Roitt
`
`
`
`Lassen - Exhibit 1044, p. 1
`
`

`

`qjfi
`
`© 1971, 1974, 1977, 1980, 1984, 1988,
`1991,1994,1997 by Blackwell Science Ltd
`Editorial Offices:
`Osney Mead, Oxford OX2 OEL
`25 John Street, London WC1 N ZBL
`23 Ainslie Place, Edinburgh EHS 6A]
`350 Main Street, Malden
`MA02148 5018, USA
`54 University Street, Carlton
`Victoria 3053, Australia
`
`Other Editorial Offices:
`
`Blackwell Wissenscha fts—Verlag Gmbl-l
`Kurftirstendamm 57
`10707 Berlin, Germany
`Zehetnergasseé
`A-1140 Wien
`Austria
`
`All rights reserved. No pa rt of
`this publication may be reproduced,
`stored in a retrieval system, or
`transmitted, in any form or by any
`means, electronic, mechanical,
`photocopying, recording or otherwise,
`except as permitted by the UK
`Copyright, Designs and Patents Act
`1988, without the prior permission
`of the copyright owner.
`
`Set by Excel Typesetters Co., I-Iong Kong
`Printed and bound in Italy
`by Rotolito Lombarda S.p.A., Milan
`
`The Blackwell Science logo is a
`trade mark of Blackwell Science Ltd,
`registered at the United Kingdom
`Trade Marks Registry
`
`First published 1971
`Reprinted 1972 (twice), 1973 (twice)
`Second edition 1974, Reprinted 1975
`Third edition 1977, Reprinted 1978,1979
`Fourth edition 1980, Reprinted 1982, 1983
`Fifth edition 1984
`Sixth edition 1988, Reprinted 1988
`Reprinted with corrections 1989
`Seventh edition 1991
`Eighth edition 1994, Reprinted 1996
`Ninth edition 1997
`
`Spanish editions 1972, 1975,1978,1982,
`1988,1989, 1993
`Italian editions 1973, 1975, 1979, 1986,
`1988, 1990, 1993, 1995
`Portuguese editions 1973, 1979, 1983
`French editions 1975, 1979,1990
`Dutch editions 1975, 1978, 1982
`Japanese editions 1976, 1978, 1982, 1986,1988
`German editions 1977, 1984, 1988, 1993
`Polish edition 1977
`Greek editions 1978, 1989, 1992
`Turkish edition 1979
`Slovak edition 1981
`Indonesian editions 1985, 1991
`Russian edition 1988
`Korean edition 1991
`ELBS editions 1977, 1982, 1988, Reprinted 1991
`Chinese (Taiwan) editions 1991, 1994
`
`DISTRIBUTORS
`Ma rston Book services Ltd
`PO Box 269
`Abingd on
`Oxon OX14 4YN
`(Orders: Tel: 01235 465500
`Fax: 01235 465555)
`
`USA
`Blackwell Science, Inc.
`Commerce Place
`350 Main Street
`Malden, MA 02148 5018
`(Ordm's: Tel: 800 759 6102
`617 388 8250
`Fax: 617 388 8255)
`
`Canada
`Copp Clark Professional
`200 Adelaide St West, 3rd Floor
`Toronto, Ontario MSH 1W7
`(Orders: Tel: 416 5974616
`800 815-9417
`Fax: 416 597-1617)
`
`Australia
`Blackwell Science Pty Ltd
`54 University Street
`Carlton, Victoria 3053
`(Orders: Tel: 3 9347 0300
`Fax: 3 9347 5001)
`
`Catalogue records for this title
`are available from the British Library
`and the Library ofCongress
`ISBN 0-86542-729-1
`
`Lassen — Exhibit 1044, p. 2
`
`Lassen - Exhibit 1044, p. 2
`
`

`

`_
`
`v
`
`CONTENTS
`
`PREFACE .............. .
`
`.
`
`I ....... xiii
`
`ACKNOWLEDGEMENTS .
`
`...........
`
`.
`
`.
`
`.
`
`.
`
`xiv
`
`Target cells are told to commit suicide .............. 19
`Eoslncphils ...................... .
`.
`20
`SUMMARY ................... .
`.
`.
`20
`
`.
`
`A““““’.‘"' ”5 """""" '
`
`'
`
`' """" X"
`
`2 - Specific acquired Immunity, 22
`
`USER GUIDE ..................... .
`
`.
`
`.
`
`xix
`
`22
`.
`.
`.
`THE NEED FOR SPECIFIC IMMUNE MECHANISMS
`ANTIBODY—THE SPECIFIC ADAPTOR .......... 22
`
`T H E BAS I S OF I M M U N 0 I'OGY
`
`3
`6
`
`PA RT 1
`
`.
`
`.
`Innate Immunity, 3
`'
`1
`EXTERNAL BARRIERS AGAINST INFECTION .......
`PHAGOCYTIC CELLS KILL MICROORGANISMS .....
`Polymorphs and macrophages are dedicated ‘professional'
`6
`phagocytes ..........................
`6
`The polymorphonuclear neutrophil ...............
`6
`Themacrophage .......................
`6
`Microbes are engulfed by phagocytosis ........... ,
`.
`.
`.
`8
`There Is an array of killing mechanisms ..............
`8
`Killing byreacllve oxygenlntermediates ............
`9
`Killing by reactive nitrogen Intermediates ............
`Killing by preformed antlmlcroblals ............... 10
`COMFLEMENT FACILITATES PHAGOCYTOSIS ...... 11
`Complement and Its activation .................. 11
`03 undergoes elow spontaneous cleavage ........... 1 1
`03!) levels are normally tightly controlled ............ 1 1
`03 convertase is stabilized on microbial surfaces ........ 1 1
`The post-03 pathway generates a membrane attack complex
`.
`.
`12
`.
`Complement hasa range of defensive biologicalfunclicns .
`.
`.
`.
`12
`I 03b adheres to complement receptors ............ 12
`2 Biologicallvcctlve fragments are released .......... 12
`3 The terminal complex can induce membrane lesions .....
`14
`COMPLEMENT CAN MEDIATE AN ACUTE
`INFLAMMATORY REACTION ........ . ....... 14
`The mast cell plays a central role ................. 14
`Macrophages can also do It ...............
`.
`.
`.
`15
`HUMORAL MECHANISMS PROVIDE A SECOND
`DEFENSIVE STRATEGY ................... 18
`Acute phase proteins Incrmse in response to infection ....... 16
`Interfercns Inhibit viral replication ................ 18
`EXTRACELLULAR KILLING ................. 18
`Natural killer (NK) cells .....................
`18
`
`Antibody Initiates a new complement pathway Cclassical’) ..... 23
`Complexed antibody activates phagocytic cells .......... 25
`CELLULAR BASIS OF ANTIBODY PRODUCTION .
`.
`I
`I
`.
`25
`Antibodies are made by lymphocytes ............... 25
`Antigen selects the lymphocytes which make antibody ...... 26
`The needforclonclexpansion means humeral Immunity must
`26
`be acquired ........................ .
`ACQUIRED MEMORY .................... 28
`Secondary antibody responses are better
`............ 28
`ACQUIRED IMMUNITY HAS ANTIGEN SPECIFICITY . ..
`30
`Discrimination between different antigens ............ 30
`Discrimination between self and nonself ............. 32
`VACCINATION DEPENDS ON ACQUIRED MEMORY .
`.
`.
`32
`CELL-MEDIATED IM MUNITY PROTECTS AGAINST
`INTRACELLULAR ORGANISMS ............... 33
`Cytokine-prcducing T-cells help macrophagesto kill intracellular
`parasites ............................ 33
`Vlrally infected cells can be killed by cytotoxic T-cells and
`ADCC ............................. 33
`I MM UNO PAT H0 LO GY ..................... 35
`SU M MARY .........................
`35
`FURTHER READING ....................
`37
`General re'ading ......................
`37
`Reference work ......................
`37
`Historical .........................
`38
`In-depth series forthe advanced reader ............ 38
`Current Information .....................
`38
`Multiple choice questions ..................
`38
`Electronic publications (linked to ‘Rol‘rl‘s Essential
`Immunology) .......................
`Majorjournals ................... .
`.
`.
`
`39
`39
`
`.
`
`Lassen — Exhibit 1044, p. 3
`
`Lassen - Exhibit 1044, p. 3
`
`

`

`vi
`
`CONTENTS
`
`PART 2 - THE RECOGNITION OF ANTIGEN
`
`3 - Antibodies, 43
`
`.
`
`.
`
`THE BASIC STRUCTURE Is A FOUR-PEPTIDE UNIT .
`AMINO ACID sequences REVEAL VARIATIONS IN
`IMMUNOGLOBULIN STRUCTURE ..............
`IMMUNOGLOBULIN GENES .................
`lmmunoglobulins are encoded by multiple gene segments .....
`A special mechanism eliects VDJ recombination
`STRUCTURAL VARIANTS OF THE BASIC
`IMMUNOGLOBULIN MOLECULE ..............
`lsotypes ............................
`Ailotypes ............................
`Idiotypee ............................
`IMMUNOGLOBULINS ARE FOLDED INTO GLOBULAR
`DOMAINS WHICH SUBSERVE DIFFERENT
`FU N CTIO N S ..........................
`Immunoglobulin domains have a characteristic structure .....
`The variable domain binds antigen ................
`Constant region domains determine secondary biological function .
`IMMUNOGLOBULIN CLASSES AND SUBCLASSES
`Immunoglobulin G has major but varied roles in extracellular
`defenses ............................
`Activation of the classical complement pathway
`The diversity of Fay receptors ,,,,,,,,,,,,,,,,,
`Nonprecipltaling 'univalent’ antibodies .............
`Immunoglobulin A guards the mucosal surfaces .........
`Immunoglobulin M provides a defense against bacteremla .....
`immunoglabulin D is a cell surface receptor ............
`Immunoglobulin E triggers inflammatory reactions ........
`immunoglabulins are further subdivided into subclasses
`SU MMARY .........................
`FURTHER READING .....................
`
`.
`
`.
`
`.
`
`4 - Membrane receptors for antigen, 63
`THE B-CELL SURFACE RECEPTOR FOR ANTIGEN .
`The B-cell inserts a transmembranc immunoglabulin info
`Its surface ...........................
`The surface Immunoglobulin is complexed with associated
`membrane proteins .......................
`THE T-CELL SURFACE RECEPTOR FOR ANTIGEN
`.
`The receptor for antigen Is a transmembrane heterodimer .....
`There are two classes of T-ceii receptors .............
`The encoding of T-oeil receptors is similar to that of
`lmmunogiobuiins ...................... .
`The CD3 complex is an integral panel the T-cell receptor ......
`THE GENERATION OF DIVERSITY FOR ANTIGEN
`RECOGNITION
`.......................
`Inlrochain amplification of diversity .............
`.
`.
`Random VDJ combination increases diversity geometrically .
`.
`.
`Playing with the junctions ..................
`Interchain amplification .....................
`Somatic hypermulutian .....................
`THE MAJOR HISTOCOMPATIBILITY COMPLEX
`(M NO) ............................
`Glass | and class II molecules are membrane-bound
`heterodimers ........................ .
`MHC classi ........................
`MHC ciassil ...................... .
`.
`
`.
`
`43
`
`45
`45
`45
`46
`
`47
`47
`47
`50
`
`50
`50
`51
`51
`51
`
`59
`59
`
`63
`
`63
`
`64
`65
`65
`65
`
`66
`67
`
`68
`69
`69
`69
`70
`70
`
`71
`
`71
`71
`71
`
`Complement genes contribute to the remaining class ill region
`72
`otthe MHC .........................
`72
`.
`.
`Gene map ofthe MHC ................ .
`.
`The genes at the MHC display remarkable polymorphism ..... 75
`Nomenclature ................ ,
`.
`.
`.
`.
`.
`.
`75
`inheritance of the MHC ................... .
`77
`The tissue distribution of MHC molecules
`............ 77
`MHC functions ......................... 77
`SUMMARY ......................... 78
`FURTHER READING ................. ,
`.
`79
`
`83
`83
`
`88
`
`88
`
`.
`
`.
`
`.
`
`5 - The primary Interaction with antigen, 80
`WHAT IS AN ANTIGEN? ................... 80
`0f epifopes and antigen determinants .............. Bi
`identification of B-ceii epitopes ................. 81
`ANTIGENS AND ANTIBODIES iNTERACT BY SPATIAL
`.
`.
`COMPLEMENTARITY NOT BY COVALENT BONDING .
`Variation In hapten structure shows importance of shape .....
`Spatial complementarity of epitope and paralope can be
`demonstrated ......................... 83
`Antigen-antibody bonds are readily reversible ......... .
`84
`THE FORCES BINDING ANTIGEN T0 ANTIBODY
`BECOME LARGE AS INTERMOLEGULAR DISTANCES
`86
`BECOME SMALL .....................
`86
`i Electrostatic
`.....................
`2 Hydrogen bonding ..................... 87
`3 Hydrophobic
`....................... 87
`4Van derWaals .................... ,
`.
`87
`AFFINITY MEASURES STRENGTH 0F BINDING OF
`ANTIGEN AND ANTIBODY < ............... .
`The avidity of antiserum for antigen — the bonus effect
`ofmultivalencv .................
`THE SPECIFICITY 0F ANTIGEN RECOGNITION
`BY ANTIBODY IS NOT ABSOLUTE ............. 90
`WHAT THE T-CELL SEES .................. 9i
`Haplotype restriction revealsthe need forMHC participation
`.
`.
`.
`.
`91
`T-cellsrecognizealinearpeptidesequencefromfhe antigen .
`.
`.
`.
`91
`PROCESSING OF INTRACELLULAR ANTIGEN
`FOR PRESENTATION BY CLASS I MHC
`......... 92
`PROCESSING OF ANTIGEN FOR CLASS II MHC
`93
`.
`.
`PRESENTATION FOLLOWS A DIFFERENT PATHWAY .
`THE NATURE OF THE ‘GROOVY’ PEPTIDE ........ 96
`Binding to MHC classl .................... 96
`Binding to MHC class Ii ...................
`.
`97
`THE up T-CELL RECEPTOR FORMS A TERNARY
`98
`.
`.
`COMPLEX WITH MHC AND ANTIGENIC PEPTIDE .
`99
`.
`.
`Topology ofthelernary complex ..............
`T-CELLS WITH A DIFFERENT OUTLOOK ......... 99
`Non-classical class i molecules can also present antigen ...... 99
`MHC class I-Iike molecules .................... 99
`The family of CD1 non--MHG classl-like molecules can
`99
`.
`.
`.
`presentexotic antigens ................. .
`ya TCRs have some features at antibody ............. 100
`SUPERANTIGENS STIMULATE WHOLE FAMILIES
`OF LYMPHOCYTE RECEPTORS ............... 100
`Bacterial toxins represent one major group of T-celi
`superahtigens .................... -.
`Endogenous mouse mammary tumor viruses (MMTV) act
`as superontigens ........................ 100
`Microbescanalso provide B-cclisuperantigens
`.
`.
`.
`.
`.
`.
`.
`.
`.
`lOi
`
`.
`
`.
`
`.
`
`.
`
`. 100
`
`Lassen — Exhibit 1044, p. 4
`
`Lassen - Exhibit 1044, p. 4
`
`

`

`CONTENTS
`
`vil
`
`THE RECOGNITION OF DIFFERENT FORMS OF ANTIGEN
`By B- AND T-CELLS IS ADVANTAGEOUS TO THE
`HOST ............................ 101
`suMMARY .......................... 102
`FURTHER READING ..................... 103
`
`TECHNOLOGY
`PART 3
`6 -
`lmmunochemical techniques, 107
`ESTIMATION OF ANTIBODY IIIIIIIIIIIIIIII 107
`_
`.
`.
`Antigen—OMIDOOV Interactions m solution """""" 107
`What does serum‘anftbody content’ mean? ........ .
`. 107
`.
`.
`The classical preclpltin reaction ................ 109
`lfotln antibodiescanbedetectedb ne helomet
`N
`reci
`109
`p
`°”p
`g
`..
`.
`.
`V.
`p
`Campiexesformed by nonprecipitating antibodiescan
`feet
`ltaIed
`13
`""" . """"""""""
`p
`‘39
`Enhancement of precipitation by countercurrent
`Immunoelectrophoresis .................... 1 10
`.
`.
`.
`Measurement oiantibodyaffinity ............... 110
`_
`_
`Agglutination of antigen-coated particles ............. 111
`.
`.
`lmmunaassayfar antibody usmg solid-phase antigen ....... 112
`_
`The principle ......................... 1 12
`.
`.
`.
`A wide variety of labels is available .............. 1 13
`.
`.
`ELISA (enzyme-linked immunosorbeni assay) ........ 113
`Other labels ........................ 113
`
`W “
`
`110
`
`surface memo" ”mun“ """"""""" 1 14
`IDENTIFICATION AND MEASUREMENT OF ANTIGEN,
`.
`. 114
`,
`_
`.
`Precipitation reactionean be carried out In gels
`......... 114
`.
`.
`.
`Characterization of antigens by electrophoresis and
`I
`.
`imm”"°fi"°"°" """""""""""" ”4
`Quantification by single radial lmmunodiffusion (SRID) ..... 115
`.
`The nephelomeiric assay for antigen """""""" 1 15
`Sodium dodecyi sulfate-polyacryiamide gel electrophoresis
`(SDS—PAGE)foranalysis oflmmunopreclpiiates and
`lmmunobloiting ........................ 116
`The Immunoassay ofantlgens
`................. 117
`Immunoassay on multiple microspofs
`............ 118
`Epiiopemapplng ........................ 118
`T-celiepitopes ........................ 118
`B-cell epitopes ........................ 1 19
`DETECTION OF IMMUNE COMPLEX FORMATION .
`.
`.
`. 120
`MAKING ANTIBODIES 1.09““ """""" 120
`The monoclonal antibody revolution ............... 120
`ggizmggmfodies """"""""""" 1:?
`"""""""""""
`Human monoclonals can be made ............... 123
`Engineering antibodies ..................... 124
`.
`.
`.
`Fields 0' antibodies """"""""""" ‘25
`Drugs conbebased on me CDRsofminibodles ......... 125
`PURIFICATION or ANTIGENS AND ANTIBODIES
`BY AFFINITY CHROMATOGMPHY """""" 126
`NEUTRALIZATION or eiaLoeicAL ACTIVITY ...... 127
`To detectantlbody
`127
`', """""""""
`'
`'
`Using antibody as an Inhibitor ................. 127
`SUM MARY .......................... 128
`F
`URTHER READING ..................... 129
`
`7 - Cellular techniques, 130
`ISO
`
`LATION OF LEUKOCYTE SUBPOPULATIONS ..... 130
`
`Buikiechniques ........................ 130
`Separation based on physical parameters
`. .......... 130
`Separation exploiting biological parameters
`.
`.
`.
`.
`.
`.
`.
`.
`.
`. 131
`Selection by antibody cooling ................. 131
`Cell selection bytne FACS .................... 131
`Enrichmentof antigen-specific populations ............ 131
`IMMUNOHISTOCHEMISTRY — LOCALIZATION
`i ..... 133
`.
`0F ANTIGENS IN CELLS AND TISSUES
`.
`.
`lmmunofluorescence techniques ................ 133
`Direct testw1th labeled antibody ............... 134
`Indirectfesfforanfibody
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`,
`.
`.
`.
`.
`.
`. 134
`Hi h resolution with the confocal microsco e
`135
`g
`_
`p """""
`Flow cytafluorimeiiy ..................... 135
`.
`.
`.
`Thede'em" “"d'm'“t'°”°”"m°e"5 """""" ‘37
`Otherlabeledaniibodymeihods ..........,... 139
`.
`.
`.
`.
`Localization intissues ofa gene product
`........... . 139
`ASSESSMENT or FUNCTIONAL ACTIVITY ........ 1411
`,
`The activity of phagocytic cells .................. 140
`.
`Lymphocyte responsiveness ................... 140
`.
`..
`,
`.
`.
`Umiiing dilution analySis ................
`.
`.
`. 140
`_
`,
`,
`Enumeration of antibody-fanning cells .............. 140
`.
`The immunotluorescence sandwich test ............ 140
`.
`Plaque techniques ..................... 141
`.
`.
`.
`A
`.
`AnaIVSis of functional activity by cellular reconstitution ...... 142
`.
`.
`.
`Radiation chimeras ...................... 142
`.
`.
`.
`Mice With severe combined Immunodeficiency (SCID) ...... 142
`Cellular interactions In vlf o
`142
`.
`.
`r """""""""
`Probing function with antibodies ................. 143
`GENETIC ENGINEERING 0F CELLS ............ 144
`.
`.
`.
`Insertion and modification of genes in mammalian cells ...... 144
`Introducin new enesintoanlmals
`144
`g.
`, g
`.
`,
`. """"""""
`Establishing designer mice bearing new genes ........ 144
`cries introduced Into embr onlc stem cells
`Tran
`144
`Gesfie them In humans
`Y
`"""" i 45
`SUMMARY W
`""""""" '
`‘
`'
`'
`'
`14'}
`""""""" ‘ """"""
`FURTHER READING """"""""""" 148
`
`PART 4 - THE ACQUIRED IMMUNE
`RESPONSE
`
`8 - The anatomyofthe immune response, 151
`THE SURFACE MARKERS OF CELLS IN THE IMMUNE
`SYSTEM
`151
`THE NEED r011 ORGANIZED LYMPHOID TISSUE ..... 151
`LYMPHOCYTES TRAFFIC BETWEEN LYMPHOID
`TISSUES ......................... . 153
`Lymphocytes home to their specific tissues ............ 153
`Transml ration occurslnthree sla
`s
`153
`Ste 19mm anmmn
`”‘3 """"""" 153
`p '
`9
`9 """""""""
`Step 2: 132 lntegrln activation and cell flattening
`........ 154
`Ste 3-Transml ratlonlntottietlssue(dla edesls)
`154
`p '
`9
`p
`""""
`Acloser iookatthe interacting receptors and their ligands ..... 156
`ENCAPSULATED LYMPH NODES .............. 156
`5-09“ areas
`156
`T cell areas """""""""""""" 157
`'
`...........................
`SPLEEN lllllllllllllllllllllllll 158
`MUCOSAL-ASSOCIATED LYMPIIOID TISSUE (MALT).
`,
`. 161
`Intestinal lymphocytes ..................... 162
`BONE MARROW CAN BE A MAJOR SITE or ANTIBODY
`SYNTHESIS llllllllllllllllllllllll 162
`
`Lassen — Exhibit 1044, p. 5
`
`Lassen - Exhibit 1044, p. 5
`
`

`

`vlll
`
`CONTENTS
`
`THE ENJOYMENT OF PRIVILEGED SITES ........ . 163
`THE HANDLING OF ANTIGEN ............... 163
`Macrophages are general antigen-presenting cells ........ 163
`Interdlgltating dendrltlc cells present antigento T—Iymphocytes
`.
`.
`. 164
`Follicular dendrltlc cells stimulate B-cells In germinal centers
`.
`.
`. 165
`M-cells provide the gateway to the mucosal lymphoid system .
`.
`.
`1156
`SUMMARY .......................... 166
`FURTHER READING ..................... 167
`
`9 » Lymphocyte activation. 168
`IMMUNOCOMPETENT T- AND B-CELLS DIFFER IN
`MANY RESPECTS ....................... 168
`T-LYMPHOCVTES AND ANTIGEN-PRESENTING CELLS
`INTERACT THROUGH SEVERAL PAIRS 0F ACCESSORY
`MOLECULES ......................... 169
`THE ACTIVATION OF T-CELLS REOUIRES
`TWO SIGNALS
`....................... 189
`PROTEIN TYROSINE PHOSPHORYLATION IS AN EARLY
`EVENT IN T-CELL SIGNALING ............... 170
`DOWNSTREAM EVENTS FOLLOWING TOR
`SIGNALING ......................... 171
`
`The phosphotldylinosltol pathway ................ 171
`p21 rastunction ........................ 171
`Control at IL—2 gene transcription ................ 171
`Further thoughts on the control at T-celi triggering ......... 171
`A serial TCR engagement model tor T-cell activation
`...... 171
`Damping T-cell enthusiasm .................. 1 73
`B-CELLS RESPOND TO THREE DIFFERENT TYPES
`OF ANTIGEN ......................... 173
`1 MM thymus-Independentantigens .............. 173
`2 Type 2 thymus-Independent antigens .............. 173
`3 Thymus-dependentantlgens ................. 174
`The need for collaboration with T—helper cells
`......... 174
`.
`Antigen processing by B-cells .....
`......... 174
`THE NATURE OF B-CELI. ACTIVATION ........... 176
`B-cells are stimulated by cross-linking surface lg ......... 176
`T-helper cells activate resting B-cells ............... 177
`SUMMARY .......................... I77
`FURTHER READING ................. 178
`
`10 - The production of effectors, 179
`A SUCCESSION OF GENES ARE UPREGULATED
`179
`BY T-CELL ACTIVATION ...............
`. 179
`CYTOKINES ACT AS INTERCELLULAR MESSENGERS .
`. 180
`Cytoklne action lstranslent and usually short range
`.
`.
`.
`.
`.
`.
`.
`Cytoklnes actthrough cell surface receptors ........... 180
`The gp 130 subtamlly .................... 182
`The [to and ye receptor subiamilles .............. 182
`Signal transduction through cytoklne receptors .......... 182
`Cytokines oiten have multiple eftects ............... 182
`Network interactions ...................... 1 83
`DIFFERENT CD4 T-CELL SUBSETS CAN MAKE
`DIFFERENT CYTOKINE PATTERNS ............. 184
`The bipolar THl/THZ concept .............. .
`.
`.
`, 184
`Interactions with cells at the Innate Immune system may bias
`the Tilt/TH2 response ...................... 185
`ACTIVATED T-CELLS PROLIFERATE IN RESPONSE
`TO CYTOKINES .................... .
`
`186
`
`. 186
`T-CELL EFFECTORS IN CELL-MEDIATED IMMUNITY .
`Cytokines mediate chronic intiammatory responses ........ 186
`Early events ........................
`186
`Chemotoxls ........................
`187
`Macrophage activation ...................
`187
`Combating viral iniection .................. . 187
`Killer T—cells ....................... .
`. 188
`The generation of cytotoxic T-cells ............
`.
`188
`The lethal process .....................
`188
`lntlammatlon must be regulated ................. 189
`PROLIFERATION AND MATURATION 0F B-CELL
`RESPONSES ARE MEDIATED BY CYTOKINES ...... 189
`WHAT IS GOING ON IN THE GERMINAL CENTER?
`.
`.
`. 190
`THE SYNTHESIS OF ANTIBODY .............. 191
`IMMUNOGLOBULIN CLASS SWITCHING OCCURS
`IN INDIVIDUAL II-CELLS .................
`Class-switched B-ceils are subject to high mutation rates alter
`the initial response ....................... 193
`FACTORS AFFECTING ANTIBODY AFFINITY
`.
`IN THE IMMUNE RESPONSE .............
`The ettect of antigen dose ...................
`Maturation ofcttlnity ................... .
`MEMORY CELLS ......................
`The memory population is not simply an expansion oi
`corresponding naive cells .................... 196
`SUMMARY .......................... 198
`FURTHER READING .................. .
`199
`
`. 194
`194
`. 195
`195
`
`192
`
`11 - Control mechanisms, 201
`ANTIGEN IS.A MAJOR FACTOR IN CONTROL ...... 201
`Antigens oan tntertere with each other .............. 202
`ANTIBODY EXERTS FEEDBACK CONTROL ........ 202
`T-CELL REGULATION .................... 203
`T—helper cells ........ -.' ........... .
`.
`.
`.
`203
`Neil suppression
`,
`.
`. .................. 204
`Suppressorand helper epltcpes can be discrete ....... . 204
`CharacIeristlcs ot suppression ................. 204
`Suppression due to T—Tlnteraction on antigen-presenting cells .
`. 206
`Ettector T-cells are guided to the appropriate target by we
`207
`.
`surtoce molecules ................. .
`207
`IDIOTYPE NETWORKS ..................
`. 207
`Jeme’s network hypothesis
`.
`.
`............
`.
`. 208
`Evidence tor ldiotyplc networks .............. .
`Anti-Idlotype can be Induced by outolcgous ldiotypes ...... 208
`A network Is evident in early life
`........... 208
`T-cells can also do it ..................... 209
`Preoccupatlon ot networks with salt ............... 209
`ldiotyplc regulation of Immune responses ............ 210
`Manipulation at the immune response through idlotypes ...... 211
`THE INFLUENCE OF GENETIC FACTORS ......... 213
`Some genes ctfect general responsiveness ............ 213
`Immune response llnked to immunoglobulln genes ........ 213
`Immune response can be intluenced bythe MHC ......... 213
`The Ir genes map to the H—ZI region and control T—B
`cooperation ......................... 214
`ARE THERE REGULATORY IMMUNONEUROENDOCRINE
`N ETWORKS? ......................... 216
`A neuroendocrine feedback loop aftecting immune responses
`.
`,
`. 216
`Sex hormones come into the picture ............... 21 7
`
`Lassen — Exhibit 1044, p. 6
`
`Lassen - Exhibit 1044, p. 6
`
`

`

`CONTENTS
`
`ix
`
`Inching towards ‘psycholmmunalagy' .............. 217
`EFFECTS OF DIET, EXERCISE, TRAUMA AND AGE
`0" IM M "N'"
`----------------------- 2‘ 8
`Malnutrition diminishes the effectiveness of the Immune
`response ____________________________ 218
`ormrfactors __________________________ 219
`SW MARY lllllllllllllllllllll y
`_
`’
`. 220
`FURTHER READING ..................... 221
`
`12 ' Ontogeny and phylogeny, 223
`THE NIuLTIPorENTIAL HEMATOPOIETIG erN cELL
`GIVES RISE TO THE FORMED ELEMENTS
`OF THE Moog ,,,,,,,,,,,,,,,,,, 223
`THE THVMUS PROVIDES THE ENVIRONMENT
`FOR T~GELL DIFFERENTIATION ........... 225
`Bone marrow stem cells become immunocompetent T—cells
`in the thymus _________________________ 226
`T-CELL ONTOGENY _______________ 227
`Differentiation is accompanied by changes In surface markers
`.
`.
`. 227
`Receptor rearrangement .................... 228
`The development of alt receptors ............... 229
`The development of 75 receptors llllllllllllll 229
`Cells are positively selected for self-MHc restriction In the thymus .
`. 229
`T-CELL TOLERANCE _________________ 23]
`The induction of immunological tolerance is necessaryto avoid
`self-reactivity ......................... 231
`Self-tolerance can be induced in the thymus ............ 231
`lntrathymlc olonai deletion leads to self-tolerance ......... 231
`Factors aflecflng positive or negative selection in the thymus .
`_
`_ 233
`7.09" tolerance can be due to clonol energy lllllllllll 234
`Infectious unergy ______________________ 235
`Lack of communication can cause unresponsiveness ....... 235
`some DIFFERENTIATE IN THE FETAL LIVER
`AND THEN IN BONE MARROW lllllllllllllll 238
`3.1 AND 3,2 CELLS REPRESENT TWO DISTINCT
`popu ”no N s """""""""""""""""" 237
`DEVELOPMENT OF 3-05“ spEcmcn-y lllllllll 233
`The sequence of Immunoglobulln gene rearrangements ...... 238
`The Importance of allelic exclusion lllllllllllllll 240
`Different specific responses can appear sequentially ....... 240
`THE moucnou 0F 10L: RANGE m
`3. mm; H OGYTES ____________________ 240
`Tolerance can be caused by clonal deletion and clonal anergy
`.
`.
`. 240
`Tolerance may result from helpless B-cells IIIIIIIIIII 241
`THE OVERALL RESPONSE IN THE NEONATE
`______ 243
`THE EVOLUTION OF THE IMMUNE RESPONSE _____ 243
`Recognition of self is fundamental for multicellular organisms
`.
`.
`. 243
`Invertebrates hcvs microbial defense mechanisms ........ 244
`Adaptive Immune responses appear with the vertebrates ...... 245
`Lower vertebrates ...................... 245
`Hensappea, llllllllllllllllllllllll 245
`Generation of antibody diversity ............... , 247
`THE EVOLUTION OF DIsTINcT 3- AND T-cELL
`LINEAoEs WAs AccOMPANIED at THE DEVELOPMENT
`or SEPARATE srrEs FOR DIFFERENTIATION ...... 247
`CELLULAR necosNITION NOLEcULEs EXPLOIT
`THE IMNuuosLoeuuN GENE SUPERFAMILY ...... 247
`SUM MARY ________________________ 248
`FURTHER ITEADI No ..................... 250
`
`PART 5 .
`
`I M M u NITY TO IN FE CTION
`
`13 - Adversarial strategies during infection, 253
`
`INFLAMNIATION REVISITED ................ 254
`Mediators of Inflammation .................. . 254
`Leukocytes bind to endothellal cells through pdlred adhesion
`"WINGS --------------------------- 255
`initiation of the acute Inflammatory response ........... 255
`The ongoing inflammatory process ................ 256
`Regulation and resolution oflnilammatlon ........... . 257
`Chmmclnflummafim --------------------- 258
`EXTRACELLULAR BACTERIA SUSCEPTIBLE T0 KILLING
`at PHAsochosIs AND COMPLEMENT ......... 258
`Bacterlaisurvlvalstrategles ................... 258
`Emmi! PMQOW'OS'S -------------------- 258
`Challenging the complement WSW“ -------------- 259
`Antigenic variation ...................... 260
`The host counter-attack ..................... 26Q
`70“” neutralization ---------------------- 251
`Opsonlzaiion otbacterla
`-
`i’ -------------- 261
`Some further effects of complement -------------- 263
`The secretory immune system protects the external mucosal
`surfaces --------------------------- 263
`Some specliic bacterial infections ................. 265
`BACTERIA WHICH GROW ”I A" INTRAcELI-“UR
`"WT“ -
`. -------------------- 267
`Bacterial gamblls
`-
`-l-
`-
`-.
`,
`- -------------- 267
`03'5”“ '5 by T-ceII-medlated ImmunIty (CMI) ----------- 253
`Activated macrophages kill Intracellular parasites ......... 268
`Examples of intracellular bacterial infections ........... 269
`LISIBIICI ........................... 269
`Tuberculosis ------------------------- 269
`“WW -
`'
`I
`-
`.
`-
`-
`.
`-
`.
`.
`-
`-
`-
`-
`; ----------- 271
`IMMUNITY T0 VIRAL INFECTION .
`.' ........... 271
`Immunity can be evaded by antigen changes ........... 271
`Changing antigens by arm and ShIfI .............. 271
`Mutation can produce antagonistic T-cell epitopes ....... 272
`5°” "”555 “a" ““9” “""99" Prose-“mg ----------- 272
`Viruses can interfere with immune effector mechanisms ...... 272
`Playing games With the complement system .......... 272
`Suboluglng cell-medIated Immunity .............. 272
`Protection by serum antibody .................. 273
`Localtactore """""""""""""" 273
`Cell-mediated immunity gets to the intracellular virus ....... 273
`NK cells can kill viraliy Infected targets ............. 273
`‘cytotoxIcT-cells (Tc) arecruclalelements In Immunityto
`' 275
`-
`-
`I,
`'"Iecfion by budding viruses
`-
`.
`.'
`-
`-‘ ----- .'
`-
`4 275
`-
`-
`Cytoklnes recruit “99‘0“ and Wow“ a cordon WWII”
`”‘1'”de has a parttoo -------------------- 275
`IMMUNITY 1'0 FutIGl ----------------- 275
`IMMUNITY To FAIIAsmc INFEcTIONs ......... 27s
`The "03”680001985 ----------------------- 275
`Humml'mmunlh’
`--------------------- 277
`GEN-medlatefilmmunliv -------------------- 278
`EVUSIveslrulegIesbthe parasite ................ 279
`Refilsfflncmefiwormechunlsms -------------- 279
`AVO'd'ng"fl“gemmgnmon Wham“ ------------ 28°
`Deviation of the host immune response ............ 281
`'mmuml’a'hmgv --------------------- . 281
`
`-
`
`Lassen — Exhibit 1044, p. 7
`
`Lassen - Exhibit 1044, p. 7
`
`

`

`SUMMARY .......................... 281
`FURTHER READING ..................... 284
`
`PRIMARY T-CELL DEFICIENCY ............... 315
`COMBINED IMMUNODEFICIENCY
`............ 317
`
`GONTE NTS
`
`14 - Prophylaxis, 285
`PASSIVELY ACOUIRED IMMUNITY ............. 285
`Maternaity acquired antibody .................. 2B7
`Pooled human y-globulln .................... 287
`Cultured antibodies made to order ............... . 287
`Adoptive transfer of cytotoxic T-ceils ............... 288
`VACCINATION ........................ 238
`Herd immunity ......................... 288
`Strategic considerations .................... 288
`KILLED ORGANISMS AS VACCINES ........... 288
`LIVE ATTENUATED ORGANISMS HAVE MANY
`ADVANTAGES AS VACCINES ................ 289
`Classical methods of attenuation ................ 290
`Attenuation by recombinant DNA technology ............ 290
`Microbial vectors for other genes ................. 290
`Constraints on the use of attenuated vaccines ........... 293
`SUBUNIT VACCINES CONTAINING INDIVIDUAL
`PROTECTIVE ANTIGENS .................. 293
`The use of purified components ................. 293
`Antigens can be synthesized through gene cloning ........ 294
`The naked gene itself acts as a vaccine .............. 295
`EPITOPE-SPECIFIC VACCINES MAY BE NEEDED ..... 296
`Epitopes can be mimicked by synthetic peptides ......... 297
`E-celi epitopes ........................ 297
`T-ceii epitopes ........................ 297
`Making the peptides immunogenic ............... 298
`Ialotypes can be exploited as epliops-spealfic vaccines ...... 299
`Unwanted epitope-Icss mutants can correctly fold desired
`discontinuous B-cell epitopes .................. 299
`CURRENT VACCINES .................... 299
`EXPERIMENTAL VACCINES IN DEVELOPMENT ...... 300
`Malaria ............................. 300
`Schistosomiasis ......................... 302
`Cholera ............................ 303
`Tuberculosis .......................... 303
`ADJUVANTS ......................... 303
`Depot effects .......................... 303
`Macrophage activation ........... . ......... 304
`Specific effects on lymphocytes ................. 304
`NEw APPROACHES TO THE PRESENTATION
`OF ANTIGEN ......................... 304
`SUM MARY .......................... 305
`FURTHER READING ..................... 307
`
`PART 6
`
`CLIH ICAL IMMUNOLOGY
`
`15 - Immunodeficiency. 31 1
`PRIMARY IMMUNODEFICIENCY STATES
`IN THE HUMAN ....................... 311
`DEFICIEHCIES OF INIIATE IMMUNE MECHANISMS .
`.
`. 311
`Phagocytic cell defects ..................... 311
`Complement system dellciencles ................. 312
`Defects In control proteins ................... 312
`Deficiency of components of the complement pathway ..... 31 3
`PRIMARY B-CELL DEFICIENCY ............... 314
`
`. 317
`
`Mutation in the common cytokine receptor yu chain causes SCID .
`SCID can be due to mutations In purine salvage
`pathway enzymes ....................... 31 7
`other SCID variaMs ....................... 317
`RECOGNITION OF IMMUNODEFICIENCIES ........ 317
`SECONDARY IMMUNODEFICIENCY ............ 318
`ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS).
`. 319
`AIDS results from infection by a human immunodeficiency virus
`(HIV) ............................. 319
`The infection of cells by HIV .................... 319
`The AIDS Infection depletes helper T-cells ............. 321
`Natural history of the disease ................. 321
`Mechanisms of depletion ..............

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket